Rheinmetall's €500m Bundeswehr Deal Lands as Analysts Wrangle Over the F126 Fallout
Published on 08/23/2026 at 20:24 | Redaktion boerse-global.deThe order pipeline at Rheinmetall keeps growing, but the share price tells a decidedly more complicated story. The Düsseldorf-based defence group has locked in another Bundeswehr contract worth more than €500 million for 149 additional protected and unprotected mobile medical stations, building on a framework agreement signed with the Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support at the end of 2024. Series production is scheduled to begin in the first quarter of 2027.
The fresh order adds to a backlog that Rheinmetall pegged at over €80 billion in mid-August, with management targeting a corridor of €100 billion to €120 billion by year-end. While the medical-station contract barely moves the needle on that scale, it underscores how Bundeswehr demand now extends well beyond traditional weapons platforms.
That breadth of demand, however, has not translated into share-price momentum. The stock closed Friday at €1,156.40, down 0.3 percent on the day and roughly 42 percent below its 52-week high of €2,007.00 reached in early October last year. Since the start of 2025, the shares have shed 26 percent — a sharp correction following the massive run-up of previous years.
The drag is largely attributable to Berlin. After the cancellation of the F126 frigate programme, the German government lowered Rheinmetall's revenue forecast for the current year by €300 million, according to media reports. The company now expects sales of €13.7 billion to €14.2 billion, down from the previously guided €14.0 billion to €14.5 billion. The operating margin guidance of around 19 percent remains unchanged.
Should investors sell immediately? Or is it worth buying Rheinmetall?
The second-quarter figures, published roughly two weeks ago, did little to settle nerves. Revenue came in at €3.289 billion, operating profit at €562 million, and first-half sales reached €5.2 billion with markedly improved profitability. Since the release, the share price has gained just 0.6 percent — a muted response that reflects how the trimmed guidance is weighing on sentiment.
Analyst reactions have been sharply divided. Warburg Research reaffirmed its Buy rating on Wednesday with a price target of €1,500 following the final quarterly numbers. On the same day, MWB Research reportedly cut its target to €1,050 and recommended selling — a level below the current trading price. RBC initiated coverage on August 11 with an Outperform rating and a price target of €1,600, the highest among current estimates. Jefferies followed on August 14, lifting its target from €1,300 to €1,350 while keeping a Buy stance. The spread between roughly €1,050 and €1,600 illustrates how far apart the street remains on whether the slashed revenue outlook undermines the long-term growth narrative.
A separate order from Denmark, reported on Tuesday, briefly put Rheinmetall in the spotlight. The low-double-digit-million-euro contract from the Scandinavian country was cited in market commentary as a short-term driver, though it is unlikely to resolve the debate around the lowered annual forecast. What it does demonstrate is that European demand for defence equipment remains intact despite individual programme setbacks like F126.
Beyond day-to-day operations, Rheinmetall is also working on its technological positioning. A cooperation agreement with Boeing aims to accelerate Germany's path toward manned-unmanned aircraft systems (CCA). Such partnerships are less about near-term revenue and more about establishing the group as a systems provider in the European defence market over the long haul.
Technically, the stock sits 5.6 percent above its 50-day moving average but remains clearly below the 200-day average — a configuration that lends support to the more cautious analyst voices. For investors, the central question persists: can a record order book compensate for the reduced guidance and the uncertainty stemming from the frigate programme loss in the quarters ahead? The wide divergence in price targets suggests the market has yet to reach a consensus.
Ad
Rheinmetall Stock: New Analysis - 23 August
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
